share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Apr 16 16:11
Summary by Moomoo AI
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 11,447 Class A shares of the company on 04/16/2024, as per the latest filing. These shares, valued at approximately $87,725, were originally acquired as founders shares on 09/01/2016 as part of compensation from the issuer. This upcoming transaction follows a series of sales over the past three months, where Borgeson sold a total of 103,110 shares, generating gross proceeds of $1,124,868.48.
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 11,447 Class A shares of the company on 04/16/2024, as per the latest filing. These shares, valued at approximately $87,725, were originally acquired as founders shares on 09/01/2016 as part of compensation from the issuer. This upcoming transaction follows a series of sales over the past three months, where Borgeson sold a total of 103,110 shares, generating gross proceeds of $1,124,868.48.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more